Description
A Phase 3 Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer
Contact Person: Tanya Pozniansky
Please contact l: pozniat@sutterhealth.org about Adjuvant AFT-19
Location: PAMF (Peninsula/South Bay)
View study details on ClinicalTrials.govPrincipal Investigator
Co-Investigator(s)
Derrick Wong, M.D., Kim-Son Nguyen, M.D., Edmund W. Tai, M.D., David S. Leibowitz, M.D., FACP, Janet Wang, M.D., Glenn D. Wong, D.O., Gillian L. Hsieh, M.D., Michael C. Wu, M.D., Natalia Colocci, M.D., Ph.D., Priya Chakravarthi, M.D., Paula D. Kushlan, M.D., Huan T. Ha, M.D., Albert Pisani, M.D., M. Dwight Chen, M.D., Irene Wu, M.D., Monique de Bruin, M.D., MPH
Recruitment Status
Active, Recruiting
Start Date
February 01, 2019
Related Studies
Genomic Health Oncotype DX AR-V7
Investigators: Rajeswari Chellappah, M.D., Kristin N. Arreola, M.D., David S Yee, M.D., MPH, Brian K. Kim, M.D, Kristie A. Bobolis, M.D., Nitin Rohatgi, MD, Sivakumar Reddy, M.D., Vijay Suhag, M.D.
Locally Advanced (ECOG-ACRIN EA8183)
Investigator: Edmund W. Tai, M.D.